NCT02912143 German Pediatric Hemophilia Research Database
| NCT ID | NCT02912143 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Goethe University |
| Condition | Hemophilia A |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2017-01-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2017-01-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The German Pediatric Hemophilia Research Database will collect data on the prophylactic and therapeutic use of factor concentrates, complications, outcome measures (joint scores, QoL) and living circumstances in newly diagnosed children with hemophilia.
Eligibility Criteria
Inclusion Criteria: * hemophilia A or B * FVIII/FIX \<1% to 25% * informed consent Exclusion Criteria: * no consent
Contact & Investigator
Christoph Königs, PhD
PRINCIPAL INVESTIGATOR
Goethe University
Frequently Asked Questions
Who can join the NCT02912143 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Hemophilia A. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02912143 currently recruiting?
Yes, NCT02912143 is actively recruiting participants. Contact the research team at christoph.koenigs@kgu.de for enrollment information.
Where is the NCT02912143 trial being conducted?
This trial is being conducted at Frankfurt am Main, Germany.
Who is sponsoring the NCT02912143 clinical trial?
NCT02912143 is sponsored by Goethe University. The principal investigator is Christoph Königs, PhD at Goethe University. The trial plans to enroll 800 participants.